Figure 2 (IMAGE)
Caption
Stealth performance of IDP1. (Left) Blood concentration profiles after intravenous administration. IDP1 (red) remained in circulation more than four times longer than conventional PEG (light blue). (Right) Cellular uptake of nanoparticles by colon cancer cells (Colon26) and immune cells (RAW264.7 macrophages). IDP1-coated nanoparticles (light purple) showed markedly reduced uptake compared to uncoated particles (dark blue).
Credit
Eijiro Miyako
Usage Restrictions
Reporters may use these materials freely in news coverage with appropriate credit information.
License
Original content